The US Surgical Matrices Market continued to advance in Q318, up +10.3% YoY, fueled by continued rapid adoption of allograft breast matrices and the resurgence of synthetic hernia matrices.
According to BioMedGPS’
SmartTRAK Financial Dashboard,
in Q318, the US Surgical Matrices Market grew +10.3% YoY. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted...
Among the many interesting topics covered in the Q318 US Surgical Matrices Market Recap are: